Click here to view the original post by Healio Ophthalmology.
In addition to our own original articles, the Retina Consultant team expertly curates relevant news and research from leading publications.to provide our readers with a comprehensive view of the retina & ophthalmology landscape, Full credit belongs to the original authors and publication.
By clicking the link above, you will be leaving our site to view an article from its original source.
Sharpen your perspective. Get our weekly analysis of the news shaping the retina industry.
Click here to read the Cover Story, “Specialists navigate changing, challenging landscape of geographic atrophy management.”
Geographic atrophy management could benefit greatly from the combination of novel therapies and AI-driven imaging technology.
However, while our U.S. colleagues have FDA-approved complement inhibitors available but no tools, in Europe, we have approved tools, namely the RetInSight/Topcon GA Monitor, but not the treatments. While we wait to hopefully have access to both in Europe and the U.S., how can we take best advantage of this situation?
Obviously, we can provide